SANTA MARIA, Calif.,
March 15, 2019 /PRNewswire/
-- Hardy Diagnostics, an ISO 13485 certified manufacturer and
distributor of medical devices for microbiological procedures, has
formed a partnership with EliTechGroup. Hardy Diagnostics is now an
authorized distributor of EliTech's MYCOFAST US, a rapid
system to detect, enumerate and identify genital Mycoplasma
hominis and Ureaplasma urealyticum. This simple-to-use
system saves hospitals and clinics time, cuts cost and
improves the reliability of their overall urogenital testing
protocols.
EliTechGroup, an IVD specialty company from Puteaux,
France, was founded in 1997 and
has maintained a long history of creating quality, boutique
products for the laboratory. EliTechGroup is a privately held group
of worldwide manufacturers and distributors of in vitro
diagnostic equipment and reagents. By bringing together IVD
specialty companies that offer innovative products and solutions,
EliTechGroup has become a major contributor in advancing clinical
diagnostics to laboratories in the proximity market, those
operating closer to the patient. Their mission is perfectly in sync
with Hardy Diagnostics' mission to "diagnose and prevent disease"
and to promote good health around the world. "We're very excited
for this opportunity to partner with EliTech," says Andre Hsiung, director of technical services at
Hardy Diagnostics. "MYCOFAST US is a fantastic,
cost-effective diagnostic that quickly provides solutions to
problems in reproductive and urogenital health."
The MYCOFAST US technology saves time and money by
increasing the efficiency and accuracy of urogenital testing.
EliTech has made significant impact in the clinical industry by
improving reliability of testing using its new technology. The
MYCOFAST US system takes 24 hours for a positive result,
with an additional 24 hours to confirm a negative. This is a
streamlined version of the traditional culture media method, with
enhanced sensitivity. While molecular methods are much faster, the
nature of this kind of diagnosis is seldom urgent, thus MYCOFAST
US is an ideal, cost-effective alternative solution to both
traditional culture media as well as PCR methods for Mycoplasma
hominis and Ureaplasma urealyticum.
ADDITIONAL INFORMATION ABOUT HARDY DIAGNOSTICS
– Hardy Diagnostics is an FDA licensed
and ISO13485 verified manufacturer of medical devices for
microbiological procedures in clinical laboratories. Hardy
Diagnostics was founded in 1980 in Santa
Barbara by Jay Hardy.
Hardy Diagnostics manufactures over 2,700 different products
for the culture and identification of bacteria and fungi. Among its
offerings are unique products used to culture and detect pathogens,
such as the well-known Carrot Broth, a liquid media used to detect
Group B Streptococcus in pregnant women. Over 9,000 laboratories
throughout the nation rely on Hardy Diagnostics for their
supplies.
Today, Hardy Diagnostics employs about 400 people and
maintains nine distribution centers throughout the U.S. The company
became 100 percent employee-owned in 2015 as an ESOP (Employee
Stock Ownership Plan). Manufacturing takes place at its
headquarters in Santa Maria,
California, and at a facility in Springboro, Ohio. The company also exports
products through over 80 foreign distributors. The company's
mission is to "partner with its laboratory customers to prevent and
diagnose disease." For more information, visit
www.HardyDiagnostics.com/mycofast.
CONTACT:
Contact Person: Joel Tefft
Company Name: HARDY DIAGNOSTICS
Voice Phone Number: (805) 346-2766
FAX Number: (805) 346-8199
Email Address: TefftJ@HardyDiagnostics.com
Website: www.HardyDiagnostics.com
Related Images
mycofast-us.jpg
MYCOFAST US
This simple-to-use system saves hospitals and clinics time, cuts
cost and improves the reliability of their overall urogenital
testing protocols.
mycofast-us.jpg
MYCOFAST US
The MYCOFAST US system takes 24 hours for a positive result, with
an additional 24 hours to confirm a negative. This is a streamlined
version of the traditional culture media method, with enhanced
sensitivity.
mycofast-us.png
MYCOFAST US
MYCOFAST US is an ideal, cost-effective alternative solution to
both traditional culture media as well as PCR methods for
Mycoplasma hominis and Ureaplasma urealyticum.
Related Links
For more Information on MYCOFAST US
Company Website
Related Video
http://www.youtube.com/watch?v=hrzFqRRd4nY
View original content to download
multimedia:http://www.prnewswire.com/news-releases/hardy-diagnostics-and-elitech-form-strategic-distribution-partnership-300813304.html
SOURCE Hardy Diagnostics